콘텐츠로 건너뛰기
Merck
  • Mannich bases of scutellarein as thrombin-inhibitors: design, synthesis, biological activity and solubility.

Mannich bases of scutellarein as thrombin-inhibitors: design, synthesis, biological activity and solubility.

Bioorganic & medicinal chemistry (2012-11-08)
Nian-Guang Li, Shu-Lin Song, Min-Zhe Shen, Yu-Ping Tang, Zhi-Hao Shi, Hao Tang, Qian-Ping Shi, Yi-Fan Fu, Jian-Ao Duan
초록

Two series of 8-aminomethylated derivatives were prepared by Mannich reaction of scutellarein (2) with appropriate aliphatic amines, alicyclic amines and formaldehyde. All the compounds were tested for their thrombin inhibition activity through the analyzation of prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FIB). The antioxidant activities of these target products were assessed by 1,1-diphenyl-2-picrylhydrazyl radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl (DPPH) assay using 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay method and the solubility were assessed by ultraviolet (UV). The results showed that morpholinyl aminomethylene substituent derivative (3d) demonstrated stronger anticoagulant activity, better water solubility and good antioxidant activity compared with scutellarein (2), which warrants further development as a agent for ischemic cerebrovascular disease treatment.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Scutellarein, ≥98% (HPLC)